The Ontario government says it is fast-tracking the rollout of six “breakthrough” cancer drugs through a pilot program meant to speed up access for Ontarians.
Through the Funding Accelerated for Specific Treatments (FAST) program – a three-year pilot program – Ontarians will get access to new drugs for lung, prostate, liver and colorectal cancers, as well as leukemia and lymphoma.
The province says it expects to fast-track additional cancer drug approvals in the coming months.
Since October 2025, six cancer drugs have now been accelerated for funding through the FAST pilot, giving cancer patients access to the following life-saving treatments:
TAGRISSO: Used to treat lung cancer
SCEMBLIX: Used to treat a type of leukemia
NUBEQA: Used to treat prostate cancer
CALQUENCE: Used to treat lymphoma
OPDIVO with YERVOY: Combination therapy used to treat a type of colorectal cancer
OPDIVO with YERVOY: Combination therapy used to treat a type of liver cancer
Be the first to comment